About
Vaccines
Areas of Focus
Categories
Contract ResearchContract ManufacturingContract ManufacturingContract ResearchContract ResearchContract ResearchContract ResearchVaccineContract ManufacturingContract Research
Clinical Trials (17)
View allTotal Trials
17
As Lead Sponsor
14
As Collaborator
3
Total Enrollment
13,726
By Phase
PHASE1: 8PHASE3: 6PHASE1/PHASE2: 2PHASE2/PHASE3: 1
By Status
COMPLETED: 14ACTIVE_NOT_RECRUITING: 2UNKNOWN: 1
Clinical Trials Pipeline17 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06409494Lead Sponsor
Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years
PHASE1Active, not recruiting
72 participants
Started: Jul 15, 2024 · Completed: May 31, 2026
NCT06216093Lead Sponsor
Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years
PHASE1Active, not recruiting
100 participants
Started: May 8, 2024 · Completed: Sep 30, 2025
NCT05739292Lead Sponsor
Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old
PHASE1Completed
60 participants
Started: Feb 28, 2023 · Completed: Oct 4, 2023
NCT05559983Collaborator
Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults
PHASE1Completed
150 participants
Started: Dec 5, 2022 · Completed: Jan 23, 2024
NCT05572879Lead Sponsor
A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults
PHASE3Completed
2,600 participants
Started: Oct 1, 2022 · Completed: Feb 9, 2024
Locations (1)
Headquarters
Seoul, Korea
Map
Loading map...